Filing metadata

Accession number
0001415889-24-026168
Form type
Form 4
Filer
Protalix BioTherapeutics, Inc.
CIK
CIK 1006281
Filed
Nov 05, 2024
Reporting period
Sep 23, 2024
Description
Insider transaction

Explore SEC Filings Hub